Buy Xenetic Biosciences Stock | XBIO Stock Price & Latest News | Public
XBIO

Xenetic Biosciences

$0.00 (0.00%)Today
    Small Market Cap

    About XBIO

    Xenetic Biosciences, Inc. engages in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.08
    -0.15
    -0.23
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.23

    Actual EPS
    Q3 2020

    Stats

    Market Cap$8,17M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$2.33
    1 Year Low$0.44
    Open$1.29
    High$1.29
    Low$1.27

    Buy any stock with any amount of money.

    Download the App
    Download the app